Published in Mol Cancer on October 28, 2010
A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia. Blood Cancer J (2014) 0.83
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia. Oncotarget (2016) 0.78
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet (2005) 8.99
MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer (2007) 8.17
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood (2003) 4.54
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med (2004) 4.16
Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate? BMC Genomics (2005) 2.76
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood (2006) 2.05
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood (1995) 2.00
The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol (2005) 1.73
Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev (2007) 1.71
Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res (2006) 1.64
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
The MLL recombinome of acute leukemias. Leukemia (2006) 1.51
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood (2005) 1.46
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol (2005) 1.45
Loss of heterozygosity and microsatellite instability at the MLL locus are common in childhood acute leukemia, but not in infant acute leukemia. Blood (1999) 1.42
Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature (2010) 1.29
E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases. EMBO J (2009) 1.28
Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia. Int J Hematol (2007) 1.26
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A (2003) 1.26
Multiple mixed lineage leukemia (MLL) fusion proteins suppress p53-mediated response to DNA damage. J Biol Chem (2005) 1.23
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia (1998) 1.16
Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res (2003) 1.16
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood (2009) 1.11
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism. Br J Cancer (2009) 1.04
Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J (2001) 0.99
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol (1998) 0.99
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia (2004) 0.97
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer (2005) 0.94
Repression of the BH3-only molecule PMAIP1/Noxa impairs glucocorticoid sensitivity of acute lymphoblastic leukemia cells. Apoptosis (2009) 0.92
MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia. Genes Chromosomes Cancer (2006) 0.88
Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. Leuk Res (2008) 0.87
In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia. Br J Haematol (2007) 0.86
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines. Br J Cancer (2006) 0.86
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br J Haematol (2005) 0.84
Towards targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol (2006) 0.81
Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood (1995) 0.81
A xenograft model of infant leukaemia reveals a complex MLL translocation. Br J Haematol (2008) 0.79
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene (1999) 0.79
MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia. Leukemia (2006) 0.78
Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia. BMC Cancer (2009) 0.77
Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance. Leukemia (2002) 0.76
Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement. Leuk Lymphoma (2007) 0.76
Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate? BMC Genomics (2005) 2.76
Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea. Int J Epidemiol (2004) 1.92
The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol (2005) 1.73
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood (2007) 1.72
Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer (2006) 1.61
Hepatic iron loading in mice increases cholesterol biosynthesis. Hepatology (2010) 1.53
Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res (2007) 1.40
Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse. Cancer Res (2006) 1.36
FusionFinder: a software tool to identify expressed gene fusion candidates from RNA-Seq data. PLoS One (2012) 1.11
The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage. Cell Cycle (2006) 1.08
Identification of novel Th2-associated genes in T memory responses to allergens. J Immunol (2006) 1.06
Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy. Leuk Res (2011) 1.05
Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Mol Biotechnol (2005) 1.01
Mechanism of relapse in pediatric acute lymphoblastic leukemia. Cell Cycle (2008) 1.01
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. Eur J Cancer (2007) 1.00
Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia. BMC Genomics (2010) 0.99
A network modeling approach to analysis of the Th2 memory responses underlying human atopic disease. J Immunol (2009) 0.98
High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia. Br J Haematol (2007) 0.95
Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol (2014) 0.95
Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia. Mol Cancer (2010) 0.92
Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index. Br J Haematol (2008) 0.90
Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study. Mol Cancer (2010) 0.89
Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. Leuk Res (2008) 0.87
Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol (2007) 0.87
Is there a folate-related gene-environment interaction in the etiology of childhood acute lymphoblastic leukemia? Int J Cancer (2006) 0.87
Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. Mol Cancer Ther (2003) 0.86
Lung function, bronchial responsiveness, and asthma in a community cohort of 6-year-old children. Am J Respir Crit Care Med (2004) 0.86
In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia. Br J Haematol (2007) 0.86
MEIS proteins as partners of the TLX1/HOX11 oncoprotein. Leuk Res (2009) 0.85
Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis. PLoS One (2010) 0.84
Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent. Biochem Biophys Res Commun (2007) 0.84
A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene. Gene (2007) 0.83
The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells. Leuk Res (2003) 0.83
Regions syntenic to human 17q are gained in mouse and rat neuroblastoma. Genes Chromosomes Cancer (2004) 0.82
A microarray model system identifies potential new target genes of the proto-oncogene HOX11. Genes Chromosomes Cancer (2004) 0.82
Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia. Br J Haematol (2013) 0.81
Drug-gene modeling in pediatric T-cell acute lymphoblastic leukemia highlights importance of 6-mercaptopurine for outcome. Cancer Res (2013) 0.81
TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells. Br J Haematol (2007) 0.81
Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia. Br J Haematol (2014) 0.81
Specific alternative HOX11 transcripts are expressed in paediatric neural tumours and T-cell acute lymphoblastic leukaemia. Gene (2003) 0.80
The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse. Br J Haematol (2008) 0.80
A xenograft model of infant leukaemia reveals a complex MLL translocation. Br J Haematol (2008) 0.79
Enforced expression of HOX11 is associated with an immature phenotype in J2E erythroid cells. Br J Haematol (2002) 0.79
Effective adenovirus-mediated gene transfer into neural stem cells derived from human embryonic stem cells. Stem Cells Dev (2010) 0.78
Deletion of one copy of the p16INK4A tumor suppressor gene is implicated as a predisposing factor in pediatric leukemia. Biochem Biophys Res Commun (2004) 0.78
Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet (2005) 0.78
Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines. Neuropathology (2008) 0.78
An overview of microbial food safety programs in beef, pork, and poultry from farm to processing in Canada. J Food Prot (2007) 0.77
Detection of hemizygous deletions in genomic DNA from leukaemia specimens for the diagnosis of patients. Leuk Res (2005) 0.76
The functional mapping of long-range transcription control elements of the HOX11 proto-oncogene. Biochem Biophys Res Commun (2004) 0.76
Aberrant over-expression of a forkhead family member, FOXO1A, in a brain tumor cell line. BMC Cancer (2007) 0.75
Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia. Haematologica (2012) 0.75
Expression and purification of the human homeodomain oncoprotein HOX11. Protein Expr Purif (2002) 0.75
Aberrant expression of aldehyde dehydrogenase 1A (ALDH1A) subfamily genes in acute lymphoblastic leukaemia is a common feature of T-lineage tumours. Br J Haematol (2014) 0.75